Oncology Medical News about Lymphoma, T-Cell

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment
Leukemia and Lymphoma, 11/04/09

Kohrt H et al. – The clinical course of advanced disease is highly aggressive with frequent chemotherapy resistance and a poor prognosis. Therapeutic approaches to advanced–stage or relapsed and refractory disease, including the appropriate sequence of chemotherapy, combined modality therapy, and stem cell transplantation is not well–established. International and multicenter clinical trials are needed for this rare and aggressive disease.

<< Previous
Cyclophosphamide, doxorubicin, vincristine, methotrexate,...

Next >>
Disparities in medical care among commercially insured patients...

Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
British Journal of Haematology, 11/04/09 Relevance Score: 70%

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
Journal of Clinical Oncology, 10/12/09 Relevance Score: 70%

Association between exposure to topical tacrolimus or pimecrolimus and cancers
Annals of Pharmacotherapy, 11/16/09 Relevance Score: 68%

Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry.
Annals of Rheumatic Diseases, 10/22/09 Relevance Score: 68%

Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents
Blood, 10/13/09 Relevance Score: 68%